Palbociclib: First CDK4/6 Inhibitor in Clinical Practice for the Treatment of Advanced HR-Positive Breast Cancer
about
Palbociclib: First CDK4/6 Inhibitor in Clinical Practice for the Treatment of Advanced HR-Positive Breast Cancer
description
2016 nî lūn-bûn
@nan
2016 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2016 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
name
Palbociclib: First CDK4/6 Inhi ...... nced HR-Positive Breast Cancer
@ast
Palbociclib: First CDK4/6 Inhi ...... nced HR-Positive Breast Cancer
@en
Palbociclib: First CDK4/6 Inhi ...... nced HR-Positive Breast Cancer
@nl
type
label
Palbociclib: First CDK4/6 Inhi ...... nced HR-Positive Breast Cancer
@ast
Palbociclib: First CDK4/6 Inhi ...... nced HR-Positive Breast Cancer
@en
Palbociclib: First CDK4/6 Inhi ...... nced HR-Positive Breast Cancer
@nl
prefLabel
Palbociclib: First CDK4/6 Inhi ...... nced HR-Positive Breast Cancer
@ast
Palbociclib: First CDK4/6 Inhi ...... nced HR-Positive Breast Cancer
@en
Palbociclib: First CDK4/6 Inhi ...... nced HR-Positive Breast Cancer
@nl
P2860
P356
P1433
P1476
Palbociclib: First CDK4/6 Inhi ...... nced HR-Positive Breast Cancer
@en
P2093
Johannes Ettl
P2860
P356
10.1159/000447417
P407
P577
2016-06-01T00:00:00Z